Point72 Middle East FZE’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,141	Closed	-$135K	–	63
2023 Q4	$135K	Sell	9,141 -14,233	-61%	-$210K	﹤0.01%	624
2023 Q3	$428K	Buy	23,374 +850	+4%	+$15.6K	0.01%	443
2023 Q2	$486K	Buy	+22,524	New	+$486K	0.01%	419